These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38953507)

  • 1. Advancing targeted axillary dissection in node-positive breast cancer: insights from pooled analyses and systematic review.
    Wazir U; Mokbel K
    Br J Surg; 2024 Jul; 111(7):. PubMed ID: 38953507
    [No Abstract]   [Full Text] [Related]  

  • 2. Author response: advancing targeted axillary dissection in node-positive breast cancer: insights from pooled analyses and systematic review.
    de Wild SR; Koppert LB; van Nijnatten TJA; Kooreman LFS; Vrancken Peeters MTFD; Smidt ML; Simons JM
    Br J Surg; 2024 Jul; 111(7):. PubMed ID: 38953506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micrometastasis and axillary dissection in breast cancer.
    Badruddoja M
    Arch Surg; 2010 Oct; 145(10):1022-3; author reply 1023. PubMed ID: 20956777
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
    Cserni G
    Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Management of the Axilla: A Look at the Evidence.
    Mamounas ET
    Adv Surg; 2016 Sep; 50(1):29-40. PubMed ID: 27520860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
    Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
    J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials.
    Robertson JF; Herrod PJ; Matthew J; Kilburn LS; Coles CE; Bradbury I
    Crit Rev Oncol Hematol; 2017 Feb; 110():74-80. PubMed ID: 28109407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radicality effect of adding an interpectoral to a subpectoral approach for dissection of level III axillary lymph nodes in breast cancer.
    Barros AC; Andrade FE; Bevilacqua JL; Barros MA; Piato JR; Santos DR; Filassi JR; Nimir CC
    Tumori; 2013; 99(4):500-4. PubMed ID: 24471202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
    Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
    Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].
    Gobardhan PD; Klompenhouwer EG; Beek MA; Voogd AC; Luiten EJ
    Ned Tijdschr Geneeskd; 2013; 157(22):A5646. PubMed ID: 23714290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of axillary clearance for patients with sentinel node-positive early breast cancer.
    Benson JR; Wishart GC
    Br J Surg; 2011 Nov; 98(11):1499-500. PubMed ID: 21861266
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
    Nijveldt JJ; Rajan KK; Boersma K; Noorda EM; van der Starre-Gaal J; Kate MV'V; Roeloffzen EMA; Vendel BN; Beek MA; Francken AB
    Ann Surg Oncol; 2024 Jul; 31(7):4477-4486. PubMed ID: 38523225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer.
    Williams AD; Weiss A
    Clin Breast Cancer; 2024 Jun; 24(4):271-277. PubMed ID: 38220539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.